Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer
Top Cited Papers
- 20 February 2008
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (6), 884-889
- https://doi.org/10.1200/jco.2007.14.0566
Abstract
Purpose To investigate the safety and clinical utility of the sentinel node procedure in early-stage vulvar cancer patients. Patients and Methods A multicenter observational study on sentinel node detection using radioactive tracer and blue dye was performed in patients with T1/2 (< 4 cm) squamous cell cancer of the vulva. When the sentinel node was found to be negative at pathologic ultrastaging, inguinofemoral lymphadenectomy was omitted, and the patient was observed with follow-up for 2 years at intervals of every 2 months. Stopping rules were defined for the occurrence of groin recurrences. Results From March 2000 until June 2006, a sentinel node procedure was performed in 623 groins of 403 assessable patients. In 259 patients with unifocal vulvar disease and a negative sentinel node (median follow-up time, 35 months), six groin recurrences were diagnosed (2.3%; 95% CI, 0.6% to 5%), and 3-year survival rate was 97% (95% CI, 91% to 99%). Short-term morbidity was decreased in patients after sentinel node dissection only when compared with patients with a positive sentinel node who underwent inguinofemoral lymphadenectomy (wound breakdown in groin: 11.7% v 34.0%, respectively; P < .0001; and cellulitis: 4.5% v 21.3%, respectively; P < .0001). Long-term morbidity also was less frequently observed after removal of only the sentinel node compared with sentinel node removal and inguinofemoral lymphadenectomy (recurrent erysipelas: 0.4% v 16.2%, respectively; P < .0001; and lymphedema of the legs: 1.9% v 25.2%, respectively; P < .0001). Conclusion In early-stage vulvar cancer patients with a negative sentinel node, the groin recurrence rate is low, survival is excellent, and treatment-related morbidity is minimal. We suggest that sentinel node dissection, performed by a quality-controlled multidisciplinary team, should be part of the standard treatment in selected patients with early-stage vulvar cancer.Keywords
This publication has 31 references indexed in Scilit:
- Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomyGynecologic Oncology, 2005
- The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulvaInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survivalJournal of the American College of Surgeons, 2003
- Vulvar carcinomaCancer, 2002
- Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996European Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancerJournal of Psychosomatic Obstetrics & Gynecology, 2001
- Complete Groin Lymphadenectomy with Preservation of the Fascia Lata in the Treatment of Vulvar CarcinomaGynecologic Oncology, 2000
- The Importance of the Groin Node Status for the Survival of T1 and T2 Vulval Carcinoma PatientsGynecologic Oncology, 1995
- Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1991
- Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisionsGynecologic Oncology, 1980